Ventolin Aerosol, Metered
Product Images NDC 68071-1890

14 FDA label images from Nucare Pharmaceuticals,inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Ventolin (NDC 68071-1890). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68071 1890 6

68071 1890 6
The Ventolin HFA metered inhaler label by NuCare Pharmaceuticals, Inc. identifies a 60-canister package containing microcrystalline suspension of albuterol sulfate with HFA-134a propellant. Each actuation delivers 108 mcg of albuterol sulfate, equivalent to 90 mcg of albuterol base. The label includes lot, expiration, serial numbers, storage instructions, and manufacturer location.*
FDA Label Image

Chemical Structure (Ventolinhfa Spl Graphic 01)

Chemical Structure (Ventolinhfa Spl Graphic 01)
Chemical structure of albuterol sulfate depicting molecular arrangement including aromatic ring, hydroxyl groups, an amine side chain with a tertiary butyl group, and associated sulfate salts.*
FDA Label Image

Fev1 As Percent Change From Predose In A Large, 12-week Clinical Trial (Day 1)

Fev1 As Percent Change From Predose In A Large, 12-week Clinical Trial (Day 1)
A line graph illustrating the mean percentage change from baseline in a measured variable over a 6-hour time period. The graph compares three groups: users of CFC 11/12-propelled albuterol (2 inhalations 4 times daily), VENTOLIN HFA (2 inhalations 4 times daily), and HFA-134a placebo inhaler (2 inhalations 4 times daily). Each group is represented by distinct symbols, showing trends of change across time.*
FDA Label Image

Fev1 As Percent Change From Predose In A Large, 12-week Clinical Trial (Week 12)

Fev1 As Percent Change From Predose In A Large, 12-week Clinical Trial (Week 12)
A line graph comparing the mean percent change from baseline in a measured variable over six hours for three different albuterol inhalation treatments: CFC 11/12-propelled albuterol, VENTOLIN HFA, and HFA-134a placebo inhaler, each administered as 2 inhalations four times daily. The Y-axis represents mean percent change, and the X-axis represents time in hours.*
FDA Label Image

Figure A (Ventolinhfa Spl Graphic 04)

Figure A (Ventolinhfa Spl Graphic 04)
Illustration diagram of an albuterol sulfate metered dose inhaler labeled with parts including the metal canister, plastic actuator, mouthpiece, cap, counter, and strap. The image highlights key components of the VENTOLIN HFA aerosol inhaler device.*
FDA Label Image

Figure B (Ventolinhfa Spl Graphic 05)

Figure B (Ventolinhfa Spl Graphic 05)
Illustration showing a close-up of a VENTOLIN HFA aerosol inhaler with a dose counter displaying the number 204, highlighting the inhaler's mouthpiece and cap in a simplified graphic style on a light blue background.*
FDA Label Image

Figure C (Ventolinhfa Spl Graphic 06)

Figure C (Ventolinhfa Spl Graphic 06)
An instructional illustration showing a person holding a metered-dose inhaler, preparing to press down on the canister with a finger as indicated by a downward arrow, while inhaling through the mouthpiece. The inhaler is being activated for respiratory drug delivery.*
FDA Label Image

Figure D (Ventolinhfa Spl Graphic 07)

Figure D (Ventolinhfa Spl Graphic 07)
An instructional illustration showing a close-up of a VENTOLIN HFA inhaler actuator with a dose counter displaying '200'. The image focuses on the inhaler mouthpiece and actuator mechanism against a light blue background.*
FDA Label Image

Figure E (Ventolinhfa Spl Graphic 08)

Figure E (Ventolinhfa Spl Graphic 08)
An illustration showing a hand holding a metered dose inhaler in the mouthpiece-down position. The mouthpiece, strap, and cap are labeled, demonstrating the correct orientation for use of the inhaler device.*
FDA Label Image

Figure F (Ventolinhfa Spl Graphic 09)

Figure F (Ventolinhfa Spl Graphic 09)
An instructional illustration showing a person using an aerosol inhaler. The image demonstrates holding the inhaler upright, pressing down on the canister, and simultaneously breathing in through the mouthpiece. The text on the image reads, "Push down and breathe in."*
FDA Label Image

Figure G (Ventolinhfa Spl Graphic 10)

Figure G (Ventolinhfa Spl Graphic 10)
Instructional diagram illustrating the proper use of a metered dose inhaler. The top image shows correct operation with the mouthpiece unblocked, allowing full aerosol spray. The bottom image shows incorrect use with the mouthpiece blocked, preventing effective spray release.*
FDA Label Image

Figure H (Ventolinhfa Spl Graphic 11)

Figure H (Ventolinhfa Spl Graphic 11)
Illustration showing a hand holding an inhaler device under a running water faucet, demonstrating rinsing or cleaning the mouthpiece of the inhaler. A second inhaler is shown lying on a surface nearby.*
FDA Label Image

Figure I (Ventolinhfa Spl Graphic 12)

Figure I (Ventolinhfa Spl Graphic 12)
Illustration showing a hand holding a Ventolin HFA metered aerosol inhaler under a running faucet, demonstrating rinsing or cleaning the inhaler mouthpiece. The inhaler spray is visible as the water flows from the faucet.*
FDA Label Image

Figure J (Ventolinhfa Spl Graphic 13)

Figure J (Ventolinhfa Spl Graphic 13)
An instructional illustration showing a window with curtains at night and two types of inhaler devices, likely demonstrating usage context or timing for the respiratory drug VENTOLIN HFA (albuterol sulfate) metered aerosol inhalation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.